Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES focuses its patent filings in the Biotechnology & Pharmaceuticals technology area. The organization currently has 1 pending office action that requires a formal response. This workload is handled by 1 distinct examiner, which indicates a singular focus for the current prosecution efforts. Furthermore, the active matter is situated within 1 distinct art unit, ensuring that the technical review is conducted by a specialized group within the patent office.
The busiest examiner for this portfolio is REGA, KYLE THOMAS, who is responsible for 1 busiest examiner pending office action. Because the total number of pending office actions is 1, this examiner is currently managing the whole of the organization's active prosecution. Practitioners should analyze the specific examination patterns of REGA, KYLE THOMAS to better prepare for potential hurdles in the Biotechnology & Pharmaceuticals sector. The presence of 1 distinct examiner and 1 distinct art unit allows for a streamlined approach to prosecution without the complexity of coordinating across different technical departments.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REGA, KYLE THOMAS | 1 | 63.0% | +41.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18286072 | NOVEL FAMILY OF DNA POLYMERASES ACCEPTING 2-AMINOADENINE AND REJECTING ADENINE IN THEIR SUBSTRATES | REGA, KYLE THOMAS | — |
| Art Unit | Apps |
|---|---|
| 1636 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18286072 | NOVEL FAMILY OF DNA POLYMERASES ACCEPTING 2-AMINOADENINE AND REJECTING ADENINE IN THEIR SUBSTRATES | REGA, KYLE THOMAS | 1636 | §112Other | Non-Final OA | — | Pending | Oct 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCOMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Kyle Thomas Rega has the most, with 1 of COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
